Concepedia

Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity

Nimesh A. Patel, Luis Acaba-Berrocal, Sandra Hoyek, Kenneth C. Fan, María Ana Martinez-Castellanos, Caroline R. Baumal, C. Armitage Harper, Audina M. Berrocal, Wei-Chi Wu, Rand Spencer,

Ophthalmology · 2022 · 25 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang · New England Journal of Medicine · 2011 · 1.5K citations · Full text

, , +14

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Andreas Stahl, Domenico Lepore, Alistair R. Fielder et al. · The Lancet · 2019 · 433 citations · Full text

, , +14

Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans

Tim U. Krohne, Zengping Liu, Frank G. Holz et al. · American Journal of Ophthalmology · 2012 · 236 citations

, , +13

The Epidemiology of Retinopathy of Prematurity in the United States

Cassie A. Ludwig, Tiffany A. Chen, Tina Hernandez‐Boussard et al. · Ophthalmic surgery, lasers & imaging retina · 2017 · 156 citations

, , +10

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

Andreas Stahl, Tim U. Krohne, Nicole Eter et al. · JAMA Pediatrics · 2018 · 154 citations · Full text

, , +16